Discontinued — last reported Q3 '19
Current Liabilities
Accrued Expenses
Idexx Laboratories Accrued Expenses decreased by 31.9% to $144.62M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.3%, from $122.23M to $144.62M. Over 5 years (FY 2020 to FY 2025), Accrued Expenses shows a downward trend with a -12.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ3 2019
How to read this metric
A steady balance is normal, but a rapid increase could indicate rising operational costs or delays in vendor invoicing.
Detailed definition
This represents liabilities for expenses that have been incurred but not yet invoiced or paid, such as utilities, profes...
Peer comparison
Standard current liability found in almost all corporate balance sheets.
Metric ID:
accrued_expensesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $136.33M | $161.58M | $458.91M | $105.92M | $110.34M | $132.15M | $433.66M | $110.85M | $125.60M | $158.16M | $478.71M | $116.34M | $124.02M | $158.99M | $502.12M | $122.23M | $140.92M | $192.52M | $212.44M | $144.62M |
| QoQ Change | — | +18.5% | +184.0% | -76.9% | +4.2% | +19.8% | +228.2% | -74.4% | +13.3% | +25.9% | +202.7% | -75.7% | +6.6% | +28.2% | +215.8% | -75.7% | +15.3% | +36.6% | +10.4% | -31.9% |
| YoY Change | — | — | — | — | -19.1% | -18.2% | -5.5% | +4.7% | +13.8% | +19.7% | +10.4% | +5.0% | -1.3% | +0.5% | +4.9% | +5.1% | +13.6% | +21.1% | -57.7% | +18.3% |
Range$105.92M – $502.12M
CAGR+1.3%
Avg YoY Growth+1.0%
Median YoY Growth+4.9%
Accrued Expenses at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's accrued expenses?
- Idexx Laboratories (IDXX) reported accrued expenses of $144.62M in Q1 2026.
- How has Idexx Laboratories's accrued expenses changed year-over-year?
- Idexx Laboratories's accrued expenses increased by 18.3% year-over-year, from $122.23M to $144.62M.
- What is the long-term trend for Idexx Laboratories's accrued expenses?
- Over 5 years (2020 to 2025), Idexx Laboratories's accrued expenses has grown at a -12.6% compound annual growth rate (CAGR), from $415.65M to $212.44M.
- What does accrued expenses mean?
- Expenses the company has incurred but has not yet received a bill for or paid.